Lumature Wealth Partners’s Intersect ENT, Inc XENT Stock Holding History

Lumature Wealth Partners’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,904	Closed	-$109K	–	446
2022 Q1	$109K	Hold	3,904	–	–	0.04%	208
2021 Q4	$107K	Hold	3,904	–	–	0.04%	173
2021 Q3	$106K	Buy	+3,904	New	+$96.5K	0.04%	172

Lumature Wealth Partners's XENT Position: Q2 2022 in Review

Lumature Wealth Partners sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 3,904 shares — an estimated $109K sold.

Lumature Wealth Partners first reported a position in XENT in Q3 2021 and held it in 3 quarters. The position peaked at $109K in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

Lumature Wealth Partners reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
Lumature Wealth Partners sold 3,904 Intersect ENT, Inc shares in Q2 2022, an estimated $109K.
Lumature Wealth Partners first reported a position in Intersect ENT, Inc in Q3 2021 and held it in 3 quarters.
Lumature Wealth Partners's Intersect ENT, Inc position peaked at $109K in Q1 2022.
0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Lumature Wealth Partners's 13F filing for Q2 2022, filed 10 Aug 2022.